Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Stem Cell Mobilization”

307 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 307 results

Not applicableUnknownNCT01042717
What this trial is testing

Study of the Best Timing for Plerixafor in Autologous Hematopoietic Stem Cell Collection

Who this might be right for
Multiple MyelomaNon-Hodgkins Lymphoma
Shi, Patricia, M.D. 10
Not applicableUnknownNCT02184897
What this trial is testing

Pharmacokinetic and Pharmacodynamic Study of Lenograstim for Hematopoietic Stem Cell Mobilization

Who this might be right for
Multiple Myeloma
Asan Medical Center 24
Testing effectiveness (Phase 2)Study completedNCT00396331
What this trial is testing

AMD3100 (Plerixafor) With G-CSF in Poor Mobilizing Adult Patients Who Previously Failed Hematopoietic Stem Cell (HSC) Collection/Attempts

Who this might be right for
Autologous Stem Cell Transplantation
Genzyme, a Sanofi Company 100
Not applicableLooking for participantsNCT00001529
What this trial is testing

Improved Methods of Cell Selection for Bone Marrow Transplant Alternatives

Who this might be right for
Graft-Versus-Host DiseaseGraft-versus-leukemiaDonor Apheresis
National Heart, Lung, and Blood Institute (NHLBI) 500
Testing effectiveness (Phase 2)Study completedNCT05561751
What this trial is testing

Ph2, Study to Assess the Safety and Efficacy of GPC 100 and Propranolol With and Without G-CSF for the Mobilization of Stem Cells in Patients With Multiple Myeloma Undergoing Autologous Stem Cell Transplant

Who this might be right for
Multiple Myeloma
GPCR Therapeutics, Inc. 30
Testing effectiveness (Phase 2)Study completedNCT00322387
What this trial is testing

Mobilization of Stem Cells With Plerixafor, Chemotherapy and G-CSF in Multiple Myeloma or Non-Hodgkin's Lymphoma Patients

Who this might be right for
Lymphoma, Non-HodgkinMultiple Myeloma
Genzyme, a Sanofi Company 40
Testing effectiveness (Phase 2)Ended earlyNCT01182675
What this trial is testing

Hematopoietic Stem Cell Transplantation (HSCT) for Children With SCID Utilizing Alemtuzumab, Plerixafor & Filgrastim

Who this might be right for
Severe Combined Immunodeficiency
University of California, San Francisco 7
Testing effectiveness (Phase 2)Study completedNCT00105001
What this trial is testing

Tacrolimus and Mycophenolate Mofetil With or Without Sirolimus in Preventing Acute Graft-Versus-Host Disease in Patients Who Are Undergoing Donor Stem Cell Transplant for Hematologic Cancer

Who this might be right for
Myelodysplastic/Myeloproliferative Neoplasm, UnclassifiablePreviously Treated Myelodysplastic SyndromeRefractory Chronic Lymphocytic Leukemia+113 more
Fred Hutchinson Cancer Center 210
Testing effectiveness (Phase 2)Study completedNCT00008268
What this trial is testing

Melphalan and Filgrastim to Stimulate Peripheral Stem Cells in Patients With Multiple Myeloma

Who this might be right for
Multiple Myeloma and Plasma Cell Neoplasm
Memorial Sloan Kettering Cancer Center
Testing effectiveness (Phase 2)Study completedNCT03317899
What this trial is testing

Stem Cell Transplant With or Without Tbo-filgrastim in Treating Patients With Multiple Myeloma or Non-Hodgkin Lymphoma

Who this might be right for
Non-Hodgkin's LymphomaPlasma Cell Myeloma
Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University 77
Large-scale testing (Phase 3)Study completedNCT02288741
What this trial is testing

Tandem Melphalan and Autolog. SCT in MM Patients 60 to 70 Years of Age With and Without Induction Chemotherapy

Who this might be right for
Multiple Myeloma
WiSP Wissenschaftlicher Service Pharma GmbH 549
Testing effectiveness (Phase 2)Study completedNCT01164345
What this trial is testing

Mozobil for Autologous Stem Cell Mobilization

Who this might be right for
Non-Hodgkin's LymphomaHodgkin's LymphomaStem Cell Mobilization+1 more
Sheba Medical Center 20
Testing effectiveness (Phase 2)Study completedNCT00906945
What this trial is testing

Chemosensitization With Plerixafor Plus G-CSF in Acute Myeloid Leukemia

Who this might be right for
Leukemia, Myeloid, Acute
Washington University School of Medicine 39
Testing effectiveness (Phase 2)Ended earlyNCT00396383
What this trial is testing

Treatment With AMD3100 (Plerixafor) in MM Patients to Mobilize PBCs For Collection and for Transplantation

Who this might be right for
Multiple Myeloma
Genzyme, a Sanofi Company 9
Testing effectiveness (Phase 2)Study completedNCT01041417
What this trial is testing

Granulocyte-Macrophage Stimulating Factor in the Treatment of Peripheral Arterial Disease

Who this might be right for
Peripheral Arterial Disease
Emory University 159
Early research (Phase 1)Study completedNCT02220608
What this trial is testing

Phase I Study of Bortezomib With G-CSF for Stem Cell Mobilization in Patients With Multiple Myeloma

Who this might be right for
Multiple Myeloma
Washington University School of Medicine 10
Very early researchUnknownNCT05970185
What this trial is testing

The Value of Peripheral Blood CD34+ Cell Dynamics Monitoring in Autologous Hematopoietic Stem Cell Transplant Mobilization

Who this might be right for
Granulocyte Colony-Stimulating Factor
Zhongnan Hospital 40
Post-approval studies (Phase 4)UnknownNCT00523393
What this trial is testing

Prospective Influence of Bedtime Insulin Glargine on Mobilization and Function of Endothelial Progenitor Cells

Who this might be right for
Type 2 Diabetes
Heidelberg University 75
Testing effectiveness (Phase 2)Study completedNCT01753453
What this trial is testing

An Exploratory Safety Study to Investigate the Extent of Tumor Cell Mobilization (TCM) After Use of G-CSF Alone or G-CSF Plus Plerixafor in Multiple Myeloma (MM) Patients Who May be Poor Mobilizers of Stem Cells

Who this might be right for
Multiple Myeloma
Sanofi 23
Testing effectiveness (Phase 2)Study completedNCT01696461
What this trial is testing

A Phase II Study Evaluating the Safety and Efficacy of Subcutaneous Plerixafor

Who this might be right for
Related Donors Donating Peripheral Blood Stem Cells (PBSC) to a Family MemberAcute Myelogenous LeukemiaAcute Lymphoblastic Leukemia+5 more
Center for International Blood and Marrow Transplant Research 127
Next Page